Championing Type 1 Diabetes Awareness
Breakthrough T1D hosts its annual Government Day, bringing together nearly 200 dedicated volunteer advocates to discuss important matters concerning type 1 diabetes (T1D). This pivotal event encourages Congress to continue supporting essential T1D research, ensuring advancements that can positively impact a significant community of individuals living with this condition.
Inspiring Leadership: Congresswoman Kim Schrier
One of the event's highlights was the inspiring address from Congresswoman Kim Schrier, MD, who is notable for being the first pediatrician elected to Congress and openly lives with type 1 diabetes. Her personal experience helps shape her approach to T1D advocacy and illustrates the real-life challenges and triumphs faced by those dealing with the condition.
A Call for Continued Support
During her speech, Congresswoman Schrier emphasized the importance of the Special Diabetes Program in providing vital funding for T1D research through the National Institutes of Health (NIH). Since its inception in 1997, this program has helped accelerate critical advancements, including innovative therapies designed to improve the lives of those affected by diabetes. These discussions aim to renew the program, ensuring it continues to make a difference.
Empowering T1D Advocates
The event's volunteers play a crucial role in representing the T1D community. They meet with lawmakers to advocate for various initiatives including funding for research, improvements in diabetes management, and lowering the costs of insulin, which continues to burden many families. The shared stories and experiences from these advocates serve to humanize the impacts of diabetes and emphasize the need for continued legislative support.
Breakthrough T1D's Initiatives and Events
Looking ahead, Breakthrough T1D is preparing for Children's Congress 2025, a significant event set to occur this summer. This remarkable gathering will bring together youth delegates from around the nation to Capitol Hill, allowing them to share their experiences with Congress members. This gathering serves a dual purpose; it not only raises awareness but also empowers young individuals to be active participants in their healthcare advocacy.
About Breakthrough T1D
Breakthrough T1D is recognized as a leading global organization dedicated to type 1 diabetes research and advocacy. The mission is clear: to enhance everyday life for those living with T1D while striving towards eventual cures for the condition. The organization focuses on funding groundbreaking research, advocating for needed changes in government policies, and fostering education to empower individuals affected by T1D.
Understanding Type 1 Diabetes
Type 1 diabetes is an autoimmune condition, leading to little or no insulin production from the pancreas. This necessitates a reliance on insulin therapy and carries risks of both short-term and long-term complications, such as damage to various organs. While often diagnosed in childhood, T1D also frequently appears in adults, marking a significant portion of total diagnoses. Research continues to deepen our understanding of the causes behind T1D, which currently has no cure.
Frequently Asked Questions
What is Breakthrough T1D's primary mission?
Breakthrough T1D aims to improve the everyday lives of those living with type 1 diabetes while pushing for advancements and potential cures through research and advocacy.
Who is Congresswoman Kim Schrier?
Congresswoman Kim Schrier, MD, is the first pediatrician elected to Congress and a prominent advocate for type 1 diabetes research and awareness.
What is the Special Diabetes Program?
The Special Diabetes Program provides critical funding for type 1 diabetes research through the NIH, significantly impacting advancements in treatment and management.
When is Children's Congress 2025 taking place?
Children's Congress 2025 is scheduled for July 7-9 and will bring together young advocates to engage with lawmakers on T1D issues.
What are the complications associated with Type 1 Diabetes?
Complications can range from short-term issues like fluctuating blood sugar levels to long-term risks involving damage to the kidneys, eyes, and nerves.
